NuCana plc
NCNA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001709626
No open-market purchases or sales by NuCana plc insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $167.9K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +2 vs. previous quarter
- 10
- 13F valueReported value at the end of Q2 2026
- $167.9K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding NCNA, Q2 2026
No superinvestor reported holding NCNA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by NuCana plc insiders from Form 4, newest first.
No open-market purchases or sales by NuCana plc insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in NuCana plc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| StoneX Group Inc. | 47,043 | $71.5K | 0.00% | +47,043 | New |
| Citadel Advisors LLC | 27,099 | $41.2K | 0.00% | +13,244+95.6% | Added |
| HRT Financial LP | 16,870 | $25.0K | 0.00% | +16,870 | New |
| Glass Jacobson Investment Advisors llc | 15,000 | $22.8K | 0.01% | 00.0% | Unchanged |
| Rhumbline Advisers | 4,698 | $7.14K | 0.00% | +976+26.2% | Added |
| Citigroup Inc | 188 | $286 | 0.00% | +188 | New |
| Caitong International Asset Management Co., Ltd | 5 | $8 | 0.00% | +3+150.0% | Added |
| Morgan Stanley | 2 | $3 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 1 | $2 | 0.00% | +1 | New |
| Acadian Asset Management LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |